Document Detail


Current ESC/ESICM and ACCF/AHA guidelines for the diagnosis and management of acute heart failure in adults--are there differences?
MedLine Citation:
PMID:  19776702     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There are many similarities between the recommendations of the European and American societies (i.e., the European Society of Cardiology, the European Society of Intensive Care Medicine, the North American College of Cardiology, and the American Heart Association) on the management of acute heart failure (AHF). There is a consensus that the symptoms of AHF should be relieved as rapidly as possible, which requires combining oxygen, noninvasive ventilation, vasodilators, and diuretics. There is also a consensus that long-lasting oral treatments such as beta-blockers and angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers should be administered to patients unless they are hemodynamically unstable. The diagnosis of AHF is based on clinical signs. However, electrocardiography and chest X-ray should be performed in all AHF patients. Natriuretic peptides should be measured in doubtful cases to either confirm or exclude the diagnosis of AHF. Echocardiography should be promptly performed by cardiologists. Because a unanimous consensus between European and North American societies has now been reached, the next step is to apply the guidelines in all medical units worldwide in order to minimize morbidity and mortality of AHF patients.
Authors:
Alexandre Mebazaa
Publication Detail:
Type:  Comparative Study; Journal Article; Review    
Journal Detail:
Title:  Polskie Archiwum Medycyny Wewn?trznej     Volume:  119     ISSN:  0032-3772     ISO Abbreviation:  Pol. Arch. Med. Wewn.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-24     Completed Date:  2009-11-06     Revised Date:  2010-04-01    
Medline Journal Info:
Nlm Unique ID:  0401225     Medline TA:  Pol Arch Med Wewn     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  569-73     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology, Critical Care and SAMU, Lariboisi?re Hospital, University Paris 7, Paris, France. alexandre.mebazaa@lrb.aphp.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Algorithms
Cardiopulmonary Resuscitation / standards
Cardiotonic Agents / therapeutic use
Electrocardiography
European Union
Fibrinolytic Agents / therapeutic use
Heart Failure / diagnosis*,  prevention & control,  therapy*
Humans
Oxygen Inhalation Therapy / standards
Practice Guidelines as Topic / standards*
Societies, Medical
United States
Vasodilator Agents / therapeutic use
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 0/Fibrinolytic Agents; 0/Vasodilator Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is it safe to use a proton pump inhibitor with clopidogrel?
Next Document:  The Terri Schiavo saga: ethical and legal aspects and implications for clinicians.